Track Your CD4 Count and Viral Load! Use TheBody.com's New Health Tracker!

BROWSE TOPICS IN HIV TREATMENT:

HIV Treatment: Home Page

Just Diagnosed

HIV Medications

First Steps to Treatment

HIV Drug Resistance

Switching or Stopping Treatment

Third Line/Rescue Treatment

Hepatitis C Coinfection

Women & Pregnancy

HIV Treatment for Children

Side Effects & Health Problems

Research & Experimental Drugs

HIV Treatment in the Developing World

Fuzeon (Enfuvirtide, T-20)

The Basics | News | Research | First Person

Show Archived (Historical) Articles

Brand Name:	Fuzeon
Generic Name:	Enfuvirtide, T-20
Adult Single Dose:	Patients weighing more than 94 lbs (42.6 kg): 90 mg (1 mL) injected subcutaneously into the upper arm, thigh, or abdomen (twice a day)
Food & Liquid Restrictions:	None
Drug Class:	FI

From The Body's "Ask the Experts" Forums

» More questions

The Basics

An Overview of Fuzeon (Enfuvirtide, T-20) (Regularly Updated)
To read PDF, click here
From U.S. National Institutes of Health
Enfuvirtide (Fuzeon) (May 24, 2009)
To read PDF, click here
From AIDS InfoNet
Fuzeon (March/April 2009)
To read PDF, click here
In Positively Aware, from Test Positive Aware Network
Patient Information About Fuzeon (Enfuvirtide, T-20) (PDF) (December 2008)
From Roche
Characteristics of Fusion and Integrase Inhibitors, and CCR5 Antagonists (PDF) (November 3, 2008)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents. For the full guidelines, click here (PDF).
From AIDSinfo
Fuzeon (Enfuvirtide, T-20) (September 28, 2007)
Basic information on dosing schedules and side effects.
From U.S. Department of Veterans Affairs
Important Changes to Fuzeon Product Labeling (January 31, 2007)
From U.S. Food and Drug Administration
Fuzeon (Enfuvirtide, T-20) Patient Product Information (PDF) (November 2006)
From Roche
T-20 (Enfuvirtide, Fuzeon) (August 15, 2006)
From AIDS Treatment Data Network
Fuzeon (Enfuvirtide, T-20) Injection Instructions (PDF) (March 2003)
From Roche

First Person

Beatriz Diaz: From Silence to Success (January 2005)
Beatriz Diaz, 49, learned the hard way that loving yourself is critical to committing to HIV treatment.
In A Guide to Fuzeon: The First Fusion Inhibitor, from The Body
Greg Braxton: A Long Journey to Recovery (January 2005)
With a 27-year history of drinking, using drugs and sleeping with hundreds of women, Greg Braxton's AIDS diagnosis in 1994 came as no surprise.
In A Guide to Fuzeon: The First Fusion Inhibitor, from The Body
The Constant Survival Battle and T-20 (Winter 2002/2003)
All of Matt Sharp's other meds had failed; then it was T-20's turn.
To read PDF, click here
In ACRIA Update, from AIDS Community Research Initiative of America
A T-20 Diary (March 2002)
Fred Gormley's first few days as part of the drug's clinical trial.
In GMHC Treatment Issues, from Gay Men's Health Crisis

The Body is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.